UBS, Faces

UBS Faces a Swiss-Only Liquidity Levy as Earnings Momentum Meets Regulatory Headwinds

Published on 10/14/2026 at 12:31 | Editorial boerse-global.de

Swiss upper-house committee backs a fee on UBS for the crisis-era liquidity backstop; full Ständerat debate set for the winter session.

Pop-Art-Comic: blauer Tresor mit goldenem Schlüssel auf Halftone-Punktraster
UBS Group AG CH0244767585 als Pop-Art-Comic mit stilisiertem Tresor und goldenem Schlüssel im farbstarken Halftone-Raster Illustration mit AI erstellt.

A nine-to-zero vote in a Swiss parliamentary committee has put UBS shareholders on notice that the safety net extended during the 2023 crisis may soon come with a permanent price tag. Yesterday, the economic affairs committee of the Ständerat — Switzerland's upper house — backed a plan to enshrine the so-called Public Liquidity Backstop in ordinary law, attaching an upfront fee to the emergency funding facility that was originally created by decree during the Credit Suisse rescue.

What makes the proposal unusually pointed for the market is its scope. The committee intends to concentrate the financial burden on systemically important institutions with substantial international operations — a definition that, as things stand, captures UBS alone. The bank declined to comment when contacted by Reuters. The Swiss Bankers Association has come out against the plan, calling it discriminatory and warning of competitive disadvantages.

A Fee Tied to the Balance Sheet, Not a Flat Charge

The decisive variable for valuation sits in how the levy would be calculated. Rather than imposing a blanket charge, the committee wants the advance compensation linked to specific balance-sheet items: loss-absorbing debt instruments, collateral deposited with foreign central banks, and long-term refinancing sources such as Pfandbriefe and covered bonds. Each of those categories feeds directly into the group's funding architecture, so a levy built on them would weigh on the interest margin for as long as the state liquidity reserve exists.

How tightly or loosely lawmakers draft those parameters therefore matters enormously to the profitability of the international business. The full Ständerat debate is not scheduled until the winter session, leaving market participants to price in yet another regulatory unknown.

Washington Pulls in the Opposite Direction

Bern's push for tougher safeguards is not the whole story. The Handelsblatt reported on October 8 on the tension between two jurisdictions: while stricter Swiss rules could raise UBS's future capital needs, signals from the United States point the other way. Planned changes by the Federal Reserve to its stress-test framework could give the group extra room to maneuver in the American market. Whether those US easings can offset mounting pressure at home is now central to how the bank is valued.

Should investors sell immediately? Or is it worth buying UBS?

Cost Cuts and Liability Management as a Buffer

On the operational side, UBS is not standing still. Roughly a week ago it agreed with Northern Trust to transfer the fund administration businesses of the former Credit Suisse in Switzerland and Luxembourg, part of a plan to exit fund servicing entirely. Completion is expected in the second quarter of 2027, subject to regulatory approvals.

The bank is also cleaning up its liabilities. In early October it announced the full repayment of outstanding Senior Callable Notes totaling JPY 8,300,000,000 with a coupon of 0.904 percent, with redemption set for October 27, 2026. If cost savings continue and the Fed's relief measures take hold, capital accumulation could stay intact despite the threat of special charges.

The Earnings Picture Behind the Political Noise

The operating record offers a counterweight to the regulatory headlines. In the second quarter of 2026, earnings per share climbed to CHF 0.72 from CHF 0.62 a year earlier, underscoring how efficiency gains are strengthening the earnings base. Analysts project a solid full-year 2026 profit of USD 3.63 per share, and a meaningful dividend increase is on the table: the payout is expected to rise from CHF 0.860 last year to a forecast USD 1.26 per share.

The stock closed yesterday at EUR 42.77 on European trading venues, a 4.8 percent premium to its 200-day moving average of EUR 40.82 — a sign the market is reflecting sustained earnings strength that could offset short-term political friction. Pre-market indications put the shares at EUR 42.73, about 11 percent below the 52-week high of EUR 48.19.

Where the Risk Really Sits

The core danger is a steady erosion of return potential at the hands of the Swiss legislature. Because international peers face no comparable special charge for liquidity guarantees in their home markets, a levy that lands on UBS alone would create a structural return disadvantage. Should the added payment obligations dampen the return on equity in the affected divisions, management could be forced to scale back business lines or rework its refinancing strategy. The bankers' association's warnings about global competitive harm make clear the draft is no mere formality. If the burden rests on the bank by itself, the valuation gap to international rivals threatens to widen.

A second risk is cumulative. Bern is simultaneously deliberating stricter capital requirements. If higher capital ratios and new liquidity fees arrive at the same time, the room for future share buybacks or dividend increases shrinks noticeably. And if the integration of the former Credit Suisse stalls in individual segments, savings may no longer be able to offset the regulatory cost wave — a scenario that points to a sustained downward re-rating of the stock.

Two Dates That Matter

The coming weeks will sharpen the picture along two dimensions. As long as operating momentum holds and the group meets consensus estimates for capital generation, the political debate is likely to be treated as manageable background noise. But if the Ständerat's winter session tilts decisively toward a hard upfront fee without carve-outs for the bank, earnings estimates for 2027 and beyond face lasting pressure.

The next concrete milestone arrives on October 28, 2026, when UBS publishes its third-quarter results. That release will show how the market environment has affected net interest income and the cost base — and give investors the chance to judge whether operating growth is sufficient to absorb the regulatory costs on the horizon.

Ad

UBS Stock: New Analysis - 14 October

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

Disclaimer...

en | CH0244767585 | UBS | boerse | 70323633 |